Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 3/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.40 |
| ▸ | NAPEPLD | Q6IQ20 | 1/20 | 0.40 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 4/20 | 0.40 |
| ▸ | CNR1 | P21554 | 3/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13324790 | 1.00 | DGKA (0.44) | DGKATSHRHPGDEPHX2L3MBTL1 | |
| SCHEMBL4570246 | 0.97 | DGKA (0.47) | DGKATSHRHPGDEPHX2L3MBTL1 | |
| SCHEMBL12451260 | 0.97 | DGKA (0.47) | DGKATSHRHPGDEPHX2L3MBTL1 | |
| SCHEMBL14370086 | 0.95 | DGKA (0.45) | DGKATSHRHPGDEPHX2L3MBTL1 | |
| SCHEMBL10033435 | 0.95 | DGKA (0.49) | DGKATSHRHPGDEPHX2L3MBTL1 | |
| SCHEMBL10308812 | 0.94 | NAAA (0.44) | DGKATSHRHPGDEPHX2L3MBTL1 | |
| SCHEMBL14408858 | 0.93 | DGKA (0.43) | DGKATSHRHPGDEPHX2L3MBTL1 | |
| SCHEMBL13324822 | 0.93 | DGKA (0.43) | DGKATSHRHPGDEPHX2L3MBTL1 | |
| SCHEMBL13324815 | 0.93 | DGKA (0.43) | DGKATSHRHPGDEPHX2L3MBTL1 | |
| SCHEMBL13849633 | 0.93 | DGKA (0.47) | DGKATSHRHPGDEPHX2L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7714040-B2 | Phase change inks containing curable amide gellant compounds | XEROX CORPORATION (US) | 2010-05-11 | — | — | US | disclosed |
| US-20070123606-A1 | Phase change inks containing curable amide gellant compounds | XEROX CORPORATION | 2007-05-31 | — | — | US | disclosed |